Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

26 Oct 2018 07:00

RNS Number : 2520F
Royal Bank of Scotland Group PLC
26 October 2018
 
 

 

The Royal Bank of Scotland Group plc

Q3 2018 Interim Management Statement

 

RBS reported an operating profit before tax of £961 million for Q3 2018, compared with £871 million in Q3 2017, and £2,787 million for the year to date.

 

Q3 2018 attributable profit of £448 million and £1,336 million for the year to date.

 

Income stable in a competitive market:

Income increased by £268 million, or 2.7%, for the year to date compared with 2017. Excluding NatWest Markets and Central items and notable items in UK PBB and Commercial Banking, income was broadly stable.

Q3 2018 income increased by £485 million, or 15.4%, compared with Q3 2017 principally reflecting indemnity insurance recoveries of £272 million and lower disposal losses.

Q3 2018 net interest margin of 1.93% decreased by 8 basis points compared with Q2 2018. Excluding one-off items, net interest margin was down 5 basis points, of which 3 basis points related to competitive pressure and 2 basis points due to higher average liquidity balances.

 

Lower costs through continued transformation and increased digitisation:

Compared with 2017, other expenses for the year to date decreased by £183 million, or 3.3%, excluding VAT releases in 2017, and FTEs reduced by 6.8%.

We continue to transition from physical to digital services. 6.2 million customers now regularly use our mobile app, 14% higher than Q4 2017. In UK PBB, total digital sales increased by 22% for the year to date, representing 43% of all sales.

 

Strong capital position:

CET1 ratio of 16.7% increased by 60 basis points in the quarter reflecting further RWA reductions and the attributable profit for Q3 2018.

RWAs decreased by £4.3 billion in the quarter primarily reflecting reductions in NatWest Markets and the impact of capital initiatives in Commercial Banking.

We have taken an additional £100 million impairment charge reflecting the more uncertain economic outlook and a further net £60 million impairment charge in our Irish business in relation to ongoing sales from our loan book to further reduce the level of non performing loans. Underlying credit conditions remained benign during the quarter.

Following final settlement with the US Department of Justice, RBS declared a 2p interim dividend on 14 August 2018.

 

Outlook and recent developments (1)

We retain the outlook guidance we provided in the 2017 Annual Results document.

 

Further to previously announced plans to be operationally ready to serve our European Economic Area (EEA) customers when the UK leaves the European Union on 29 March 2019, we have received approval from the Dutch regulator (DNB) for the repurposing of the existing NatWest Markets N.V. (formerly RBS N.V.) banking licence.

 

Note:

(1)

The targets, expectations and trends (including but not limited to impairment provisions) in this document represent management's current expectations and are subject to change, including as a result of the "Risk Factors" on pages 372 to 402 of the 2017 Annual Report and Accounts and the Summary Risk Factors on pages 48 and 49 of the 2018 Interim Results. These statements constitute forward-looking statements; refer to Forward-looking statements in this document.

 

 

Business performance summary

 

 

 

 

 

 

 

 

 

Nine months ended

 

Quarter ended

 

30 September

30 September

 

30 September

30 June

30 September

Performance key metrics and ratios

2018 

2017 

 

2018 

2018 

2017 

Operating profit before tax

£2,787m

£2,822m

 

£961m

£613m

£871m

Profit attributable to ordinary shareholders

£1,336m

£1,331m

 

£448m

£96m

£392m

Net interest margin

1.99%

2.16%

 

1.93%

2.01%

2.12%

Average interest earning assets

£435,218m

£419,450m

 

£443,092m

£434,928m

£430,962m

Cost:income ratio (1)

69.1%

69.1%

 

66.7%

80.0%

67.5%

Earnings per share

 

 

 

 

 

 

- basic

11.1p

11.2p

 

3.7p

0.8p

3.3p

- basic fully diluted

11.1p

11.2p

 

3.7p

0.8p

3.3p

Return on tangible equity

5.3%

5.2%

 

5.4%

1.1%

4.5%

Average tangible equity

£33,699m

£33,964m

 

£33,492m

£33,522m

£34,465m

Average number of ordinary shares

 

 

 

 

 

 

 outstanding during the period (millions)

 

 

 

 

 

 

- basic

11,998 

11,840 

 

12,034 

12,003 

11,886 

- fully diluted (2)

12,053 

11,913 

 

12,083 

12,062 

11,943 

 

 

 

 

 

 

 

 

30 September

30 June

31 December

Balance sheet related key metrics and ratios

2018

2018

2017

Total assets

£719.9bn

£748.3bn

£738.1bn

Funded assets

£587.3bn

£597.2bn

£577.2bn

Loans and advances to customers (excludes reverse repos)

£319.6bn

£320.0bn

£323.2bn

Impairment provisions (3)

£3.9bn

£3.9bn

£3.8bn

Customer deposits (excludes repos)

£366.0bn

£366.3bn

£367.0bn

 

 

 

 

Liquidity coverage ratio (LCR)

158%

167%

152%

Liquidity portfolio

£195bn

£198bn

£186bn

Net stable funding ratio (NSFR) (4)

139%

140%

132%

Loan:deposit ratio

87%

87%

88%

Total wholesale funding

£78bn

£75bn

£70bn

Short-term wholesale funding

£14bn

£13bn

£18bn

 

 

 

 

Common Equity Tier (CET1) ratio

16.7%

16.1%

15.9%

Total capital ratio

22.1%

21.5%

21.3%

Pro forma CET 1 ratio, pre 2018 dividend accrual (5)

16.8%

16.2%

15.9%

Risk-weighted assets (RWAs)

£194.5bn

£198.8bn

£200.9bn

CRR leverage ratio

5.4%

5.2%

5.3%

UK leverage ratio

6.3%

6.0%

6.1%

 

 

 

 

Tangible net asset value (TNAV) per ordinary share

288p

287p

294p

Tangible net asset value (TNAV) per ordinary share - fully diluted

287p

286p

292p

Tangible equity

£34,672m

£34,564m

£35,164m

Number of ordinary shares in issue (millions)

12,048 

12,028 

11,965 

Number of ordinary shares in issue (millions) - fully diluted (2,6)

12,091 

12,095 

12,031 

 

Notes:

(1)

Operating lease depreciation included in income for the nine months ended 30 September 2018 - £89 million; Q3 2018 - £32 million (nine months ended 30 September 2017 - £107 million; Q2 2018 - £26 million; Q3 2017 - £35 million).

(2)

Includes the effect of dilutive share options and convertible securities. Dilutive shares on an average basis for Q3 2018 were 49 million shares and for the nine months ended 30 September 2018 were 55 million shares; (Q2 2018 - £59 million, Q3 2017 - £57 million; nine months ended 30 September 2017 - £73 million and as at 30 September 2018 were 43 million shares (30 June 2018 - 67 million shares; 31 December 2017 - 66 million shares).

(3)

30 September 2018 and 30 June 2018 prepared under IFRS 9, 31 December 2017 prepared under IAS 39. Refer to Note 2 for further details.

(4)

In November 2016, the European Commission published its proposal for NSFR rules within the EU as part of its CRR2 package of regulatory reforms. CRR2 NSFR is expected to become the regulatory requirement in future within the EU and the UK. RBS has changed its policy on the NSFR to align with its interpretation of the CRR2 proposals with effect from 1 January 2018. The pro forma CRR2 NSFR at 31 December 2017 under CRR2 proposals is estimated to be 139%.

(5)

The pro forma CET 1 ratio at 30 September 2018 excludes a charge of £120 million (1p per share) that is a reasonably foreseeable final dividend, related to Q3 2018 profits. The 30 June 2018 ratio excluded a charge of £240 million (2p per share) that was a reasonably foreseeable interim dividend related to H1 2018 profits.

(6)

Includes 9 million treasury shares (30 June 2018 - 9 million shares; 31 December 2017 - 16 million shares).

 

Business performance summary

 

Summary consolidated income statement for the period ended 30 September 2018

 

 

 

 

 

 

 

 

Nine months ended

 

Quarter ended

 

30 September

30 September

 

30 September

30 June

30 September

 

2018 

2017 

 

2018 

2018 

2017 

 

£m

£m

 

£m

£m

£m

Net interest income

6,480 

6,776 

 

2,154 

2,180 

2,304 

 

 

 

 

 

 

 

Own credit adjustments

59 

(78)

 

20 

18 

(5)

Loss on redemption of own debt

(7)

 

Strategic disposals

156 

 

Other non-interest income

3,805 

3,229 

 

1,468 

1,202 

858 

 

 

 

 

 

 

 

Non-interest income

3,864 

3,300 

 

1,488 

1,220 

853 

 

 

 

 

 

 

 

Total income

10,344 

10,076 

 

3,642 

3,400 

3,157 

 

 

 

 

 

 

 

Litigation and conduct costs

(1,190)

(521)

 

(389)

(782)

(125)

Strategic costs

(649)

(1,034)

 

(299)

(141)

(244)

Other expenses

(5,337)

(5,440)

 

(1,753)

(1,801)

(1,774)

 

 

 

 

 

 

 

Operating expenses

(7,176)

(6,995)

 

(2,441)

(2,724)

(2,143)

 

 

 

 

 

 

 

Profit before impairment losses

3,168 

3,081 

 

1,201 

676 

1,014 

Impairment losses(1)

(381)

(259)

 

(240)

(63)

(143)

 

 

 

 

 

 

 

Operating profit before tax

2,787 

2,822 

 

961 

613 

871 

Tax charge

(1,139)

(992)

 

(398)

(412)

(265)

 

 

 

 

 

 

 

Profit for the period

1,648 

1,830 

 

563 

201 

606 

 

 

 

 

 

 

 

Attributable to:

 

 

 

 

 

 

Non-controlling interests

21 

 

22 

(23)

(8)

Other owners

306 

478 

 

93 

128 

222 

Ordinary shareholders

1,336 

1,331 

 

448 

96 

392 

 

Notable items within total income

 

 

 

 

 

 

IFRS volatility in Central items (2)

(34)

175 

 

77 

17 

21 

Insurance indemnity

272 

 

272 

of which:

 

 

 

 

 

 

NatWest Markets

165 

 

165 

Central items & other

107 

 

107 

UK PBB debt sale gain

26 

176 

 

168 

FX gains/losses in Central items & other

(7)

(175)

 

(11)

19 

(67)

Commercial Banking fair value and disposal gain/(loss)

179 

52 

 

(13)

115 

52 

NatWest Markets legacy business disposal (losses)/gains

(43)

(549)

 

14 

(41)

(446)

 

 

 

 

 

 

 

Notable items within expenses

 

 

 

 

 

 

Litigation and conduct costs

(1,190)

(521)

 

(389)

(782)

(125)

of which: US RMBS

(823)

(222)

 

(21)

(803)

of which: DoJ

(1,040)

 

(1,040)

Nomura

241 

 

241 

of which: PPI

(200)

 

(200)

of which: Ulster Bank RoI

(54)

(34)

 

(37)

(8)

(1)

VAT recovery in Central items & other

80 

 

29 

 

Notes:

(1)

30 September 2018 and 30 June 2018 prepared under IFRS 9, 31 December 2017 and 30 September 2017 prepared under IAS 39. Refer to Note 2 for further information on the impact of IFRS 9 on classification and basis of preparation.

(2)

IFRS volatility relates to loans which are economically hedged but for which hedge accounting is not permitted under IFRS.

 

 

Business performance summary

 

Personal & Business Banking - UK Personal & Business Banking

 

 

 

 

Quarter ended

 

 

As at

 

30 September

30 June

30 September

 

 

30 September

30 June

31 December

 

2018 

2018 

2017 

 

 

2018 

2018 

2017 

 

£m

£m

£m

 

 

£bn

£bn

£bn

Total income

1,564 

1,570 

1,757 

 

Net loans & advances

 

 

 

Operating expenses

(959)

(746)

(819)

 

to customers

163.2 

161.9 

161.7 

Impairment losses

(70)

(90)

(78)

 

Customer deposits

183.4 

182.2 

180.6 

Operating profit

535 

734 

860 

 

RWAs

45.4 

43.4 

43.0 

Return on equity

20.9%

30.0%

34.2%

 

 

 

 

 

Net interest margin

2.76%

2.81%

2.83%

 

 

 

 

 

 

Q3 2018 performance

UK PBB now has 6.2 million regular mobile app users, 19% higher than Q3 2017 and 14% higher than Q4 2017, supporting 71% digital penetration of active current account customers. Total digital sales increased by 22% in the year to date compared with the prior period, representing 43% of all sales, compared with 36% in the prior period. In personal banking, 56% of personal loans and 60% of mortgage switching was done digitally in the year to date. In business banking, 89% of current accounts and 66% of loans less than £50,000 were originated digitally in the year to date.

Total income was £193 million, or 11.0%, lower than Q3 2017 reflecting a £168 million debt sale gain in Q3 2017 and £11 million transfer of the Collective Investment business to Private Banking. Excluding these items, income was £14 million, or 0.9%, lower than Q3 2017, including an £8 million reduction in overdraft fees. Net interest margin decreased by 5 basis points to 2.76% compared with Q2 2018 driven by ongoing mortgage margin compression partly offset by improving deposit margins as interest rates rise.

Operating expenses were £140 million, or 17.1%, higher than Q3 2017 driven by increased litigation and conduct costs of £206 million, of which £200 million related to Payment Protection Insurance. Excluding litigation and conduct costs, operating expenses were £66 million, or 8.1%, lower driven by reduced headcount reflecting continued operating efficiencies.

Net loans and advances increased by 0.8% compared with Q2 2018. Gross new mortgage lending in Q3 2018 was £8.2 billion. Mortgage new business market share was approximately 12% in Q3 2018, supporting stock share of 10%, with mortgage approval share of approximately 13%.

RWAs increased by £2.0 billion compared with Q2 2018 primarily reflecting model updates, particularly mortgages.

 

Personal & Business Banking - Ulster Bank RoI

 

 

 

 

 

 

 

 

 

 

Quarter ended

 

 

As at

 

30 September

30 June

30 September

 

 

30 September

30 June

31 December

 

2018 

2018 

2017 

 

 

2018 

2018 

2017 

 

€m

€m

€m

 

 

€bn

€bn

€bn

Total income

169 

190 

166 

 

Net loans & advances

 

 

 

Operating expenses

(188)

(140)

(141)

 

to customers

21.6 

21.6 

22.0 

Impairment

 

 

 

 

Customer deposits

20.4 

19.9 

19.8 

(losses)/releases

(68)

39 

11 

 

RWAs

18.6 

19.0 

20.2 

Operating (loss)/profit

(87)

89 

36 

 

 

 

 

 

Return on equity

(12.7%)

12.5%

4.6%

 

 

 

 

 

Net interest margin

1.72%

1.91%

1.58%

 

 

 

 

 

 

Q3 2018 performance

Total income increased by €3 million, or 1.8%, compared with Q3 2017 reflecting an increase in lending income and lower cost of deposits, with a 14 basis point increase in net interest margin, largely offset by a reduction in income from free funds. Compared with Q2 2018, net interest margin decreased by 19 basis points primarily reflecting a €13 million one-off funding benefit in the prior quarter.

Operating expenses increased by €47 million, or 33.3%, compared with Q3 2017 principally due to higher litigation and conduct costs, largely relating to customer remediation and project costs associated with legacy business issues.

A net impairment loss of €68 million includes a provision for a further non performing loan sale that we expect would result in a material reduction in our non performing exposure ratio.

RWAs reduced by €0.4 billion compared with Q2 2018 principally reflecting an improvement in credit metrics.

 

 

Business performance summary

 

Commercial & Private Banking - Commercial Banking

 

 

 

 

 

 

 

 

 

 

Quarter ended

 

 

As at

 

30 September

30 June

30 September

 

 

30 September

30 June

31 December

 

2018 

2018 

2017 

 

 

2018 

2018 

2017 

 

£m

£m

£m

 

 

£bn

£bn

£bn

Total income

789 

915 

928 

 

Net loans & advances

 

 

 

Operating expenses

(443)

(404)

(443)

 

to customers

90.1 

90.7 

97.0 

Impairment

 

 

 

 

Customer deposits

96.4 

96.4 

98.0 

(losses)/releases

(103)

(151)

 

RWAs

69.0 

71.7 

71.8 

Operating profit

243 

515 

334 

 

 

 

 

 

Return on equity

6.6%

15.9%

8.6%

 

 

 

 

 

Net interest margin

1.71%

1.66%

1.74%

 

 

 

 

 

 

Comparisons with prior periods are impacted by the transfer of shipping and other activities from NatWest Markets, the transfer of whole business securitisations and Relevant Financial Institutions to NatWest Markets in preparation for ring-fencing and the transfer of the funds and trustee depository business to RBS International. The net impact of the transfers on Q3 2017 operating profit would have been to reduce income by £81 million, operating expenses by £2 million and impairments by £34 million. The net impact on the Q2 2018 balance sheet would have been to reduce net loans and advances by £0.2 billion and RWAs by £0.4 billion. The variances in the commentary below have been adjusted for the impact of these transfers unless otherwise stated.

 

Q3 2018 performance (comparisons adjusted for transfers)

After successfully testing Bankline mobile with 750 customers, we will be launching in the Apple app store in Q4 2018. We are now onboarding 90% of new customers digitally, up from 75% as at the end of 2017 with a greater than 50% reduction in time taken to complete the application.

Total income of £789 million was £58 million, or 6.8%, lower than Q3 2017, reflecting £13 million of fair value and disposal losses compared with £28 million of gains in Q3 2017 and lower asset volumes. On an unadjusted basis, net interest margin of 1.71% increased by 5 basis points compared with Q2 2018 due to continued progress on pricing.

Operating expenses were £2 million lower than Q3 2017 reflecting lower staff costs through headcount reductions, partially offset by increased strategic, litigation and conduct costs.

Net impairment losses were £14 million lower than Q3 2017 reflecting lower single name charges.

Net loans and advances decreased by £0.4 billion compared with Q2 2018 principally reflecting the impact of active capital management, although we continue to grow in target sectors.

RWAs decreased by £2.3 billion compared with Q2 2018 primarily reflecting the net impact of capital initiatives.

 

Commercial & Private Banking - Private Banking

 

 

 

 

 

 

 

 

 

 

Quarter ended

 

 

As at

 

30 September

30 June

30 September

 

 

30 September

30 June

31 December

 

2018 

2018 

2017 

 

 

2018 

2018 

2017 

 

£m

£m

£m

 

 

£bn

£bn

£bn

Total income

195 

198 

166 

 

Net loans & advances

 

 

 

Operating expenses

(110)

(104)

(103)

 

to customers

14.2 

13.8 

13.5 

Impairment

 

 

 

 

Customer deposits

27.2 

26.4 

26.9 

(losses)/releases

(1)

--

 

RWAs

9.5 

9.4 

9.1 

Operating profit

84 

94 

66 

 

AUM

21.8 

21.3 

21.5 

Return on equity

17.3%

19.3%

13.2%

 

 

 

 

 

Net interest margin

2.54%

2.54%

2.39%

 

 

 

 

 

 

Comparisons with prior periods are impacted by the transfer of the Collective Investment Fund business from UK PBB and by the transfers of Coutts Crown Dependency and the International Client Group Jersey to RBS International. The net impact of the transfers on Q3 2017 operating profit would have been to increase income by £9 million and increase operating expenses by £3 million. The variances in the commentary below have been adjusted for the impact of these transfers, unless otherwise stated.

 

Q3 2018 performance (comparisons adjusted for transfers)

Total Income of £195 million was £20 million, or 11.4%, higher than Q3 2017, principally reflecting increased assets under management, higher lending volumes and increased deposit income. Compared with Q2 2018, net interest margin remained stable at 2.54%.

Operating expenses increased by £4 million compared with Q3 2017, as increased back-office operations costs have been partially offset by lower staff expenses, reflecting an 9.5% reduction in headcount.

Net loans and advances increased by £0.4 billion compared with Q2 2018 principally reflecting continued targeted growth in mortgage lending, whilst capital efficient lending has kept RWAs broadly stable.

Assets under management increased by £0.5 billion compared with Q2 2018, reflecting new business inflows and investment performance. In addition, Private Banking manages a further £7.1 billion of assets under management which sit in other parts of the Group. Total assets under management increased by 1.2%.

 

 

Business performance summary

 

RBS International

 

 

 

 

 

 

 

 

 

 

Quarter ended

 

 

As at

 

30 September

30 June

30 September

 

 

30 September

30 June

31 December

 

2018 

2018 

2017 

 

 

2018 

2018 

2017 

 

£m

£m

£m

 

 

£bn

£bn

£bn

Total income

155 

147 

97 

 

Net loans & advances

 

 

 

Operating expenses

(60)

(55)

(59)

 

to customers

13.0 

13.0 

8.7 

Impairment

 

 

 

 

Customer deposits

27.0 

28.5 

29.0 

(losses)/releases

(3)

 

RWAs

6.9 

6.8 

5.1 

Operating profit

92 

95 

40 

 

 

 

 

 

Return on equity

26.9%

27.9%

10.4%

 

 

 

 

 

Net interest margin

1.73%

1.72%

1.39%

 

 

 

 

 

 

Comparisons with prior periods are impacted by the transfer of the funds and trustee depositary business from Commercial Banking and by the transfers of Coutts Crown Dependency and the International Client Group from Private Banking. The net impact of the transfers on Q3 2017 would have increased income by £44 million and increased operating expenses by £3 million. The variances in the commentary below have been adjusted for the impact of these transfers, unless otherwise stated.

 

Q3 2018 performance (comparisons adjusted for transfers)

Total Income of £155 million was £14 million, or 9.9%, higher than Q3 2017 principally reflecting deposit margin benefits. Net interest margin increased by 1 basis point compared with Q2 2018 reflecting funding benefits partially offset by an increase in deposits placed with central banks.

Operating expenses were £2 million lower than Q3 2017 as a reduction in conduct costs has been partially offset by increased back-office costs, associated with becoming a non ring-fenced bank.

Net loans and advances were stable compared with Q2 2018. Customer deposits decreased by £1.5 billion, or 5.3%, reflecting higher outflows of short term placements in the Funds sector since June.

 

NatWest Markets(1)

 

Quarter ended

 

 

As at

 

30 September

30 June

30 September

 

 

30 September

30 June

31 December

 

2018 

2018 

2017 

 

 

2018 

2018 

2017 

 

£m

£m

£m

 

 

£bn

£bn

£bn

Total income

569

284

20

 

Funded assets

120.9

134.5

118.7

Operating expenses

(478)

(322)

(526)

 

RWAs

46.5

50.1

52.9

Impairment

 

 

 

 

 

 

 

 

(losses)/releases

(4)

(13)

71

 

 

 

 

 

Operating profit/(loss)

87

(51)

(435)

 

 

 

 

 

Return on equity

1.8%

(3.0%)

(15.4%)

 

 

 

 

 

 

Note:

(1) The NatWest Markets operating segment should not be assumed to be the same as the NatWest Markets Plc legal entity or group following completion of the capital reduction on 2 July 2018.

 

Comparisons with prior periods are impacted by the transfer of shipping and other activities to Commercial Banking and the transfer of whole business securitisations and Relevant Financial Institutions from Commercial Banking in preparation for ring-fencing. The net impact of the transfers on Q3 2017 operating profit would have been to increase total income by £40 million, reduce the impairment release by £34 million and reduce operating expenses by £1 million.

 

Q3 2018 performance (comparisons adjusted for transfers)

Total income increased by £509 million to £569 million compared with Q3 2017 primarily reflecting indemnity insurance recoveries in the quarter of £165 million and non recurring disposal losses in the legacy business in Q3 2017. Income of £331 million in the core business decreased by £70 million compared with Q3 2017 reflecting more muted market conditions, although customer activity remained stable.

Operating expenses decreased by £47 million, or 9.0%, compared with Q3 2017 reflecting reductions in both the core and legacy businesses, partially offset by higher strategic costs, up £36 million to £93 million, and litigation and conduct costs, up £11 million to £113 million.

Funded assets decreased by £13.6 billion compared with Q2 2018 as the business continues to manage leverage exposure in line with becoming a non ring-fenced bank.

RWAs decreased by £3.6 billion in the quarter as core RWAs reduced by £2.3 billion, primarily reflecting lower market risk, and legacy RWAs reduced by £1.3 billion. RWAs of £46.5 billion include £5.8 billion relating to Alawwal.

 

Central items & other

Central items not allocated represented a charge of £4 million in Q3 2018, principally reflecting strategic costs of £131 million, partially offset by indemnity insurance recoveries of £107 million.

 

 

Business performance summary

 

 

 

 

 

 

End-point CRR basis

 

30 September 

30 June 

31 December 

 

2018 

2018 

2017 

Risk asset ratios

 

 

 

 

CET1

16.7 

16.1 

15.9 

Tier 1

18.8 

18.1 

17.9 

Total

22.1 

21.5 

21.3 

 

 

 

 

Capital

£m

£m

£m

Tangible equity

34,672 

34,564 

35,164 

 

 

 

 

Expected loss less impairment provisions

(606)

(636)

(1,286)

Prudential valuation adjustment

(574)

(608)

(496)

Deferred tax assets

(731)

(746)

(849)

Own credit adjustments

(264)

(224)

(90)

Pension fund assets

(283)

(316)

(287)

Cash flow hedging reserve

370 

151 

(227)

Other adjustments for regulatory purposes

(129)

(235)

28 

 

 

 

 

Total deductions

(2,217)

(2,614)

(3,207)

CET1 capital

32,455 

31,950 

31,957 

AT1 capital

4,051 

4,051 

4,041 

Tier 1 capital

36,506 

36,001 

35,998 

Tier 2 capital

6,455 

6,659 

6,765 

 

 

 

 

Total regulatory capital

42,961 

42,660 

42,763 

 

 

 

 

Risk-weighted assets

 

 

 

 

 

 

 

Credit risk

 

 

 

- non-counterparty

142,500 

144,000 

144,700 

- counterparty

14,100 

15,100 

15,400 

Market risk

15,500 

17,300 

17,000 

Operational risk

22,400 

22,400 

23,800 

 

 

 

 

Total RWAs

194,500 

198,800 

200,900 

 

 

 

 

Leverage (1)

 

 

 

 

 

 

 

Cash and balances at central banks

106,500 

102,600 

98,300 

Derivatives

132,600 

151,100 

160,800 

Loans and advances

337,200 

338,100 

339,400 

Reverse repos

29,800 

38,900 

40,700 

Other assets

113,800 

117,600 

98,900 

 

 

 

 

Total assets

719,900 

748,300 

738,100 

Derivatives

 

 

 

- netting and variation margin

(136,900)

(153,400)

(161,700)

- potential future exposures

42,700 

46,200 

49,400 

Securities financing transactions gross up

1,700 

2,700 

2,300 

Undrawn commitments

49,500 

50,700 

53,100 

Regulatory deductions and other adjustments

(700)

(1,200)

(2,100)

 

 

 

 

CRR Leverage exposure

676,200 

693,300 

679,100 

 

 

 

 

CRR leverage ratio%

5.4 

5.2 

5.3 

 

 

 

 

UK leverage exposure (2)

580,300 

597,700 

587,100 

 

 

 

 

UK leverage ratio% (2)

6.3 

6.0 

6.1 

 

Notes:

(1)

Based on end-point CRR Tier 1 capital and leverage exposure under the CRR Delegated Act.

(2)

Based on end-point CRR Tier 1 capital and UK leverage exposures reflecting the post EU referendum measures announced by the Bank of England in the third quarter of 2016.

 

 

Segment performance

 Segment performance

Quarter ended 30 September 2018

PBB

 

CPB

 

 

 

Central

 

 

 

Ulster

 

Commercial

Private

RBS

 

NatWest

 items &

Total

 

UK PBB

Bank RoI

 

Banking

Banking

International

 

Markets

other (1)

RBS

 

£m

£m

 

£m

£m

£m

 

£m

£m

£m

Income statement

 

 

 

 

 

 

 

 

 

 

Net interest income

1,289 

110 

 

525 

133 

124 

 

15 

(42)

2,154 

Other non-interest income

275 

41 

 

264 

62 

31 

 

534 

261 

1,468 

Own credit adjustments

 

 

20 

20 

Total income

1,564 

151 

 

789 

195 

155 

 

569 

219 

3,642 

Direct expenses - staff costs

(221)

(51)

 

(131)

(39)

(26)

 

(120)

(299)

(887)

  - other costs

(76)

(31)

 

(57)

(16)

(12)

 

(61)

(613)

(866)

Indirect expenses

(415)

(45)

 

(221)

(52)

(19)

 

(91)

843 

Strategic costs - direct

(1)

 

(8)

(2)

 

(78)

(211)

(299)

- indirect

(41)

(2)

 

(17)

(4)

(1)

 

(15)

80 

Litigation and conduct costs

(206)

(37)

 

(9)

 

(113)

(24)

(389)

Operating expenses

(959)

(167)

 

(443)

(110)

(60)

 

(478)

(224)

(2,441)

Operating profit/(loss) before impairment (losses)/releases

605 

(16)

 

346 

85 

95 

 

91 

(5)

1,201 

Impairment (losses)/releases

(70)

(60)

 

(103)

(1)

(3)

 

(4)

(240)

Operating profit/(loss)

535 

(76)

 

243 

84 

92 

 

87 

(4)

961 

Additional information

 

 

 

 

 

 

 

 

 

 

Return on equity (2)

20.9%

(12.7%)

 

6.6%

17.3%

26.9%

 

1.8%

nm

5.4%

Cost:income ratio (3)

61.3%

110.6%

 

54.3%

56.4%

38.7%

 

84.0%

nm

66.7%

Loan impairment rate

0.17%

1.18%

 

0.45%

nm

nm

 

nm

nm

0.30%

Net interest margin (%)

2.76%

1.72%

 

1.71%

2.54%

1.73%

 

0.22%

nm

1.93%

Third party customer asset rate

3.39%

2.42%

 

2.89%

2.91%

2.29%

 

nm

nm

nm

Third party customer funding rate

(0.29%)

(0.20%)

 

(0.33%)

(0.26%)

(0.11%)

 

nm

nm

nm

Average interest earning assets (£bn)

185.2 

25.4 

 

122.0 

20.8 

28.4 

 

26.7 

34.6 

443.1 

Total assets (£bn)

195.6 

25.3 

 

144.0 

21.4 

29.0 

 

253.3 

51.3 

719.9 

Funded assets (£bn)

195.6 

25.3 

 

144.0 

21.4 

29.0 

 

120.9 

51.1 

587.3 

Net loans and advances to customers (£bn)

163.2 

19.2 

 

90.1 

14.2 

13.0 

 

19.7 

0.2 

319.6 

Impairment provisions (£bn)(4)

(1.4)

(1.2)

 

(1.0)

(0.1)

 

(0.2)

(3.9)

Customer deposits (£bn)

183.4 

18.1 

 

96.4 

27.2 

27.0 

 

12.8 

1.1 

366.0 

Risk-weighted assets (RWAs) (£bn)

45.4 

16.5 

 

69.0 

9.5 

6.9 

 

46.5 

0.7 

194.5 

RWA equivalent

47.1 

16.6 

 

72.5 

9.5 

6.9 

 

49.9 

0.7 

203.2 

Employee numbers (FTEs - thousands)

24.8 

3.1 

 

8.1 

1.9 

1.7 

 

4.9 

24.1 

68.6 

 

 

 

 

 

 

 

 

 

 

 

For the notes to this table, refer to page 10. nm = not meaningful

 

 

 

 

 

 

 

 

 

 

 

Segment performance

 

Nine months ended 30 September 2018

 

PBB

 

CPB

 

 

 

Central

 

 

 

Ulster

 

Commercial

Private

RBS

 

NatWest

items &

Total

 

UK PBB

Bank RoI

 

Banking

Banking

International

 

Markets

other (1)

RBS

 

£m

£m

 

£m

£m

£m

 

£m

£m

£m

 

 

 

 

 

 

 

 

 

 

 

Income statement

 

 

 

 

 

 

 

 

 

 

Net interest income

3,831 

334 

 

1,522 

385 

343 

 

82 

(17)

6,480 

Other non-interest income

894 

129 

 

1,047 

192 

96 

 

1,149 

298 

3,805 

Own credit adjustments

 

 

59 

59 

Total income

4,725 

463 

 

2,569 

577 

439 

 

1,290 

281 

10,344 

Direct expenses - staff costs

(682)

(149)

 

(404)

(122)

(77)

 

(429)

(927)

(2,790)

- other costs

(207)

(76)

 

(157)

(44)

(45)

 

(176)

(1,842)

(2,547)

Indirect expenses

(1,279)

(133)

 

(662)

(157)

(56)

 

(292)

2,579 

 

 

 

 

 

 

 

 

 

 

 

Strategic costs - direct

(26)

 

(16)

(2)

 

(106)

(500)

(649)

- indirect

(137)

(8)

 

(50)

(11)

(4)

 

(21)

231 

Litigation and conduct costs

(210)

(54)

 

(3)

(1)

10 

 

(125)

(807)

(1,190)

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

(2,541)

(419)

 

(1,292)

(335)

(174)

 

(1,149)

(1,266)

(7,176)

 

 

 

 

 

 

 

 

 

 

 

Operating profit/(loss) before impairment (losses)/releases

2,184 

44 

 

1,277 

242 

265 

 

141 

(985)

3,168 

Impairment (losses)/releases

(217)

(34)

 

(122)

(2)

 

(8)

(381)

Operating profit/(loss)

1,967 

10 

 

1,155 

240 

265 

 

133 

(983)

2,787 

 

 

 

 

 

 

 

 

 

 

 

Additional information

 

 

 

 

 

 

 

 

 

 

Return on equity (2)

26.2%

0.5%

 

11.6%

16.3%

26.0%

 

0.2%

nm

5.3%

Cost:income ratio (3)

53.8%

90.5%

 

48.5%

58.1%

39.6%

 

89.1%

nm

69.1%

Loan impairment rate

0.18%

0.22%

 

0.18%

nm

nm

 

nm

nm

0.16%

Net interest margin %

2.79%

1.81%

 

1.67%

2.53%

1.67%

 

0.41%

nm

1.99%

Third party customer asset rate %

3.41%

2.40%

 

2.81%

2.87%

2.38%

 

nm

nm

nm

Third party customer funding rate %

(0.28%)

(0.21%)

 

(0.32%)

(0.21%)

(0.10%)

 

nm

nm

nm

Average interest earning assets (£bn)

183.4 

24.7 

 

121.8 

20.3 

27.4 

 

27.0 

30.6 

435.2 

Total assets (£bn)

195.6 

25.3 

 

144.0 

21.4 

29.0 

 

253.3 

51.3 

719.9 

Funded assets (£bn)

195.6 

25.3 

 

144.0 

21.4 

29.0 

 

120.9 

51.1 

587.3 

Net loans and advances to customers (£bn)

163.2 

19.2 

 

90.1 

14.2 

13.0 

 

19.7 

0.2 

319.6 

Impairment provisions (£bn) (4)

(1.4)

(1.2)

 

(1.0)

(0.1)

 

(0.2)

(3.9)

Customer deposits (£bn)

183.4 

18.1 

 

96.4 

27.2 

27.0 

 

12.8 

1.1 

366.0 

Risk-weighted assets (RWAs) (£bn)

45.4 

16.5 

 

69.0 

9.5 

6.9 

 

46.5 

0.7 

194.5 

RWA equivalent (RWAes) (£bn)

47.1 

16.6 

 

72.5 

9.5 

6.9 

 

49.9 

0.7 

203.2 

Employee numbers (FTEs - thousands)

24.8 

3.1 

 

8.1 

1.9 

1.7 

 

4.9 

24.1 

68.6 

For the notes to this table refer to the following page. nm = not meaningful.

 

 

 

 

 

 

Condensed consolidated income statement for the period ended 30 September 2018 (unaudited)

 

 

Nine months ended

 

Quarter ended

 

30 September

30 September

 

30 September

30 June

30 September

2018

2017

 

2018

2018

2017

 

£m

£m

 

£m

£m

£m

 

 

 

 

 

 

 

Interest receivable

8,224 

8,280 

 

2,780 

2,742 

2,818 

Interest payable

(1,744)

(1,504)

 

(626)

(562)

(514)

 

 

 

 

 

 

 

Net interest income (1)

6,480 

6,776 

 

2,154 

2,180 

2,304 

 

 

 

 

 

 

 

Fees and commissions receivable

2,433 

2,492 

 

787 

833 

826 

Fees and commissions payable

(671)

(652)

 

(220)

(244)

(204)

Income from trading activities

1,346 

832 

 

499 

382 

(52)

Loss on redemption of own debt

(7)

 

Other operating income

756 

635 

 

422 

249 

283 

 

 

 

 

 

 

 

Non-interest income

3,864 

3,300 

 

1,488 

1,220 

853 

 

 

 

 

 

 

 

Total income

10,344 

10,076 

 

3,642 

3,400 

3,157 

 

 

 

 

 

 

 

Staff costs

(3,108)

(3,576)

 

(1,022)

(1,031)

(1,129)

Premises and equipment

(972)

(1,041)

 

(328)

(274)

(363)

Other administrative expenses

(2,521)

(1,736)

 

(885)

(1,237)

(528)

Depreciation and amortisation

(544)

(630)

 

(206)

(175)

(119)

Write down of other intangible assets

(31)

(12)

 

(7)

(4)

 

 

 

 

 

 

 

Operating expenses

(7,176)

(6,995)

 

(2,441)

(2,724)

(2,143)

 

 

 

 

 

 

 

Profit before impairment losses

3,168 

3,081 

 

1,201 

676 

1,014 

Impairment losses

(381)

(259)

 

(240)

(63)

(143)

 

 

 

 

 

 

 

Operating profit before tax

2,787 

2,822 

 

961 

613 

871 

Tax charge

(1,139)

(992)

 

(398)

(412)

(265)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit for the period

1,648 

1,830 

 

563 

201 

606 

 

 

 

 

 

 

 

Attributable to:

 

 

 

 

 

 

Non-controlling interests

21 

 

22 

(23)

(8)

Preference share and other dividends

306 

478 

 

93 

128 

222 

Ordinary shareholders

1,336 

1,331 

 

448 

96 

392 

 

 

 

 

 

 

 

Earnings per ordinary share (EPS)

 

 

 

 

 

 

Earnings per ordinary share (2)

11.1p

11.2p

 

3.7p

0.8p

3.3p

 

Notes:

(1)

Negative interest on loans and advances is reported as interest payable. Negative interest on customer deposits is reported as interest receivable.

(2)

There is no dilutive impact in any period.

 

 

Notes to segment performance on pages 8 and 9.

 

Notes:

(1) Central items include unallocated transactions which principally comprise volatile items under IFRS and RMBS related charges.

(2) RBS's CET 1 target is in excess of 13% but for the purposes of computing segmental return on equity (ROE), to better reflect the differential drivers of capital usage, segmental operating profit after tax and adjusted for preference dividends is divided by notional equity allocated at different rates of 14% (Ulster Bank RoI), 11% (Commercial Banking), 13.5% (Private Banking), 16% (RBS International) and 15% for all other segments, of the monthly average of segmental risk-weighted assets incorporating the effect of capital deductions (RWAes). RBS Return on equity is calculated using profit for the period attributable to ordinary shareholders.

(3) Operating lease depreciation included in income for the nine months ended 30 September 2018 - £89 million; Q3 2018 - £32 million.

(4) Prepared under IFRS 9. Refer to Note 2 for further details.

 

Condensed consolidated statement of comprehensive income for the period ended 30 September 2018 (unaudited)

 

 

Nine months ended

 

Quarter ended

 

30 September

30 September

 

30 September

30 June

30 September

 

2018

2017

 

2018

2018

2017

 

£m

£m

 

£m

£m

£m

Profit for the period

1,648 

1,830 

 

563 

201 

606 

Items that do not qualify for reclassification

 

 

 

 

 

 

Profit/(loss) on remeasurement of retirement benefit schemes

72 

(26)

 

72 

 - 

 - 

Profit/(loss) on fair value of credit in financial liabilities DFV

 

 

 

 

 

 

through profit or loss due to own credit risk

109 

(107)

 

14 

34 

(30)

Fair value through other comprehensive income (FVOCI) (1)

61 

 - 

 

58 

 - 

Funding commitment to retirement benefit schemes (2)

(2,000)

 - 

 

 - 

(2,000)

 - 

Tax

487 

(5)

 

(13)

513 

 

(1,271)

(138)

 

131 

(1,450)

(27)

Items that do qualify for reclassification

 

 

 

 

 

 

FVOCI financial assets (1)

31 

37 

 

(168)

68 

Cash flow hedges

(822)

(983)

 

(301)

63 

(372)

Currency translation

120 

82 

 

102 

91 

(21)

Tax

224 

237 

 

127 

(29)

76 

 

(447)

(627)

 

(240)

193 

(309)

Other comprehensive loss after tax

(1,718)

(765)

 

(109)

(1,257)

(336)

 

 

 

 

 

 

 

Total comprehensive (loss)/income for the period

(70)

1,065 

 

454 

(1,056)

270 

 

 

 

 

 

 

 

Total comprehensive (loss)/income is attributable to:

 

 

 

 

 

 

Non-controlling interests

28 

30 

 

57 

(18)

(19)

Preference shareholders

94 

155 

 

20 

56 

70 

Paid-in equity holders

212 

323 

 

73 

72 

152 

Ordinary shareholders

(404)

557 

 

304 

(1,166)

67 

 

(70)

1,065 

 

454 

(1,056)

270 

Notes:

(1)

Refer to Note 2 for further information on the impact of IFRS 9 on classification and basis of preparation, periods ended 30 September 2018 and 30 June 2018 prepared under IFRS 9 and periods ended 30 September 2017 under IAS 39.

(2)

On 17 April 2018 RBS agreed a Memorandum of Understanding (MoU) with the Trustees of the RBS Group Pension Fund in connection with the requirements of ring-fencing. NatWest Markets Plc cannot continue to be a participant in the Main section and separate arrangements are required for its employees. Under the MoU, NatWest Bank Plc will make a contribution of £2 billion to strengthen funding of the Main section in recognition of the changes in covenant. The contribution was paid on 9 October 2018.

 

 

Condensed consolidated balance sheet as at 30 September 2018 (unaudited)

 

 

30 September

31 December

2018 

2017 

 

£m

£m 

 

 

 

Assets

 

 

Cash and balances at central banks

106,503 

98,337 

Net loans and advances to banks

17,625 

16,254 

Reverse repurchase agreements and stock borrowing

9,468 

13,997 

Loans and advances to banks

27,093 

30,251 

Net loans and advances to customers

319,577 

323,184 

Reverse repurchase agreements and stock borrowing

20,339 

26,735 

Loans and advances to customers

339,916 

349,919 

Debt securities

85,662 

78,933 

Equity shares

604 

450 

Settlement balances

11,213 

2,517 

Derivatives

132,574 

160,843 

Intangible assets

6,581 

6,543 

Property, plant and equipment

4,247 

4,602 

Deferred tax

1,781 

1,740 

Prepayments, accrued income and other assets

3,512 

3,726 

Assets of disposal groups

202 

195 

 

 

 

Total assets

719,888 

738,056 

 

 

 

Liabilities

 

 

Bank deposits

39,634 

39,479 

Repurchase agreements and stock lending

7,993 

7,419 

Deposits by banks

47,627 

46,898 

Customer deposits

365,985 

367,034 

Repurchase agreements and stock lending

33,113 

31,002 

Customer accounts

399,098 

398,036 

Debt securities in issue

39,067 

30,559 

Settlement balances

10,625 

2,844 

Short positions

27,676 

28,527 

Derivatives

125,333 

154,506 

Provisions for liabilities and charges

3,247 

7,757 

Accruals and other liabilities

5,602 

6,392 

Retirement benefit liabilities

2,128 

129 

Deferred tax

476 

583 

Subordinated liabilities

10,341 

12,722 

Liabilities of disposal groups

10 

 

 

 

Total liabilities

671,221 

688,963 

 

 

 

Equity

 

 

Non-controlling interests

791 

763 

Owners' equity*

 

 

Called up share capital

12,048 

11,965 

Reserves

35,828 

36,365 

 

 

 

Total equity

48,667 

49,093 

 

 

 

Total liabilities and equity

719,888 

738,056 

 

 

 

*Owners' equity attributable to:

 

 

Ordinary shareholders

41,253 

41,707 

Other equity owners

6,623 

6,623 

 

 

 

 

47,876 

48,330 

 

Condensed consolidated statement of changes in equity for the period ended 30 September 2018 (unaudited)

 

 

Share

 

 

 

 

 

 

 

capital and

 

 

 

Total

Non

 

 

statutory

Paid-in

Retained

Other

owners'

controlling

Total

 

reserves

equity

earnings

reserves*

equity

 interests

equity

 

£m

£m

£m

£m

£m

£m

£m

At 1 January 2018

12,809 

4,058 

17,130 

14,333 

48,330 

763 

49,093 

Implementation of IFRS 9 on 1 January 2018 (1)

(105)

34 

(71)

(71)

Profit attributable to ordinary shareholders

 

 

 

 

 

 

 

and other equity owners

1,642 

1,642 

1,648 

Other comprehensive income

 

 

 

 

 

 

 

 - Realised gains in period on FVOCI equity shares

(8)

 - Funding commitment to retirement benefit

 

 

 

 

 

 

 

schemes (2)

(2,000)

(2,000)

(2,000)

 - Changes in fair value of credit in financial

 

 

 

 

 

 

 

liabilities at fair value through profit or loss

109 

109 

109 

 - Other amounts recognised in equity

72 

(177)

(105)

22 

(83)

 - Amount transferred from equity to earnings

(545)

(545)

(545)

 - Recycled to profit or loss on disposal of

 

 

 

 

 

 

 

businesses (3)

90 

90 

90 

 - Tax

493 

218 

711 

711 

Ordinary share dividends paid

(241)

(241)

(241)

Preference share and other dividends paid

(306)

(306)

(306)

Shares and securities issued during the period

222 

(2)

220 

220 

Share-based payments - gross

23 

23 

23 

Movement in own shares held

19 

19 

19 

At 30 September 2018

13,050 

4,058 

16,823 

13,945 

47,876 

791 

48,667 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30 September

 

 

 

 

 

 

 

2018

Total equity is attributable to:

 

 

 

 

£m

Non-controlling interests

 

 

 

 

 

 

791 

Preference shareholders

 

 

 

 

 

 

2,565 

Paid-in equity holders

 

 

 

 

 

 

4,058 

Ordinary shareholders

 

 

 

 

 

 

41,253 

 

 

 

 

 

 

 

48,667 

*Other reserves consist of:

 

 

 

 

 

 

Merger reserve

 

 

 

 

 

 

10,881 

Fair value through other comprehensive income reserve

 

 

 

 

361 

Cash flow hedging reserve

 

 

 

 

 

 

(370)

Foreign exchange reserve

 

 

 

 

 

 

3,073 

 

 

 

 

 

 

 

13,945 

 

Notes:

(1)

Refer to Note 2 for further information.

(2)

On 17 April 2018 RBS agreed a Memorandum of Understanding (MoU) with the Trustees of the RBS Group Pension Fund in connection with the requirements of ring-fencing. NatWest Markets Plc cannot continue to be a participant in the Main section and separate arrangements are required for its employees. Under the MoU, NatWest Bank Plc will make a contribution of £2 billion to strengthen funding of the Main section in recognition of the changes in covenant. The contribution was paid on 9 October 2018.

(3)

No tax impact.

 

 

Notes

 

1. Basis of preparation

The condensed consolidated financial statements should be read in conjunction with RBS's 2017 Annual Report and Accounts which were prepared in accordance with International Financial Reporting Standards issued by the International Accounting Standards Board (IASB) and interpretations issued by the IFRS Interpretations Committee of the IASB as adopted by the European Union (EU) (together IFRS).

 

 

2. Accounting policies

In July 2014, the IASB published IFRS 9 'Financial instruments' with an effective date of 1 January 2018. For further details see pages 261 and 262 of the Group's 2017 Annual Report and Accounts, the RBS Group February 2018 IFRS 9 Transition report and Appendix 1 of the Group's 2018 Interim Results. There has been no restatement of accounts prior to 2018. The impact on the Group's balance sheet at 1 January 2018 is as follows:

 

 

 

 

 

 

 

 

Impact of IFRS 9

 

 

 

 

Expected

 

 

 

31 December

Classification &

 credit

 

1 January

 

2017 

measurement

 losses

Tax

2018 

 

£m

£m

£m

£m

£m

Cash and balances at central banks

98,337 

(1)

98,336 

Net loans and advances to banks

30,251 

(3)

30,248 

Net loans and advances to customers

349,919 

517 

(524)

349,912 

Debt securities and equity shares

79,383 

44 

(3)

79,424 

Other assets

19,323 

25 

19,348 

 

 

 

 

 

 

Total assets

738,056 

561 

(531)

25 

738,111 

 

 

 

 

 

 

Total liabilities

688,963 

85 

41 

689,089 

Total equity

49,093 

561 

(616)

(16)

49,022 

Total liabilities and equity

738,056 

561 

(531)

25 

738,111 

 

 

Total

Key differences in moving from IAS 39 to IFRS 9 on impairment loss

£m

31 December 2017 - IAS 39 impairment provision (1)

3,832 

Removal of IAS 39 latent provision

(390)

IFRS 9 12 month expected credit loss (ECL) on Stage 1 and 2

513 

Increase in Stage 2 ECL to lifetime (discounted)

356 

Stage 3 loss estimation (EAD, LGD)

73 

Impact of multiple economic scenarios

64 

1 January 2018 - IFRS 9 ECL

4,448 

 

 

 

Note:

(1) IAS 39 includes £28 million relating to AFS and LAR debt securities and £3,814 million relating to loans less £10 million on loans that are now carried at fair value.

 

The Group's principal accounting policies are as set out on pages 251 to 263 of the Group's 2017 Annual Report and Accounts. From 1 January 2018 the accounting policies have been updated to reflect the adoption of IFRS 9 as mentioned above. Other than in relation to IFRS 9 other amendments to IFRS effective for 2018, including IFRS 15 'Revenue from contracts with customers', IFRS 2 'Share-based payments' and IAS 40 'Investment Property' have not had a material effect on the Group's 2018 Interim Results.

 

Notes

 

2. Accounting policies continued

Critical accounting policies and key sources of estimation uncertainty

The judgements and assumptions that are considered to be the most important to the portrayal of the Group's financial condition are those relating to goodwill, provisions for liabilities, deferred tax, loan impairment provisions and fair value of financial instruments. These critical accounting policies and judgements are described on pages 259 to 261 of the Group's 2017 Annual Report and Accounts. From 1 January 2018, the previous critical accounting policy relating to loan impairment provisions has been superseded on the adoption of IFRS 9 for which details are included in the RBS Group February 2018 IFRS 9 Transition report and Appendix 1 of the Group's 2018 Interim Results.

 

Going concern

Having reviewed RBS's forecasts, projections and other relevant evidence, the directors have a reasonable expectation that RBS will continue in operational existence for the foreseeable future. Accordingly, the results for the period ended 30 September 2018 have been prepared on a going concern basis. 

3. Provisions for liabilities and charges

 

 

 

 

 

 

 

 

 

 

 

Litigation

 

 

 

Payment

Other

 

and other

 

 

 

protection

 customer

 

regulatory

 

 

 

insurance

 redress

DoJ (1)

(incl. RMBS)

Other

Total

 

£m

£m

£m

£m

£m

£m

 

 

 

 

 

 

 

At 1 January 2018

1,053 

870 

3,243 

641 

1,950 

7,757 

Implementation of IFRS 9 on 1 January 2018 (2)

85 

85 

Currency translation and other movements

(5)

(119)

(4)

(1)

(129)

Charge to income statement

19 

111 

133 

Releases to income statement

(10)

(1)

(5)

(15)

(31)

Provisions utilised

(152)

(115)

(90)

(52)

(100)

(509)

At 31 March 2018

901 

759 

3,033 

583 

2,030 

7,306 

RMBS transfers (1)

(567)

567 

Currency translation and other movements

209 

32 

(24)

217 

Charge to income statement

46 

1,040 

23 

93 

1,202 

Releases to income statement

(51)

(305)

(119)

(475)

Provisions utilised

(156)

(104)

(189)

(806)

(1,255)

At 30 June 2018

745 

650 

3,715 

711 

1,174 

6,995 

Transfer from accruals and other liabilities

Currency translation and other movements

46 

12 

11 

70 

Charge to income statement

200 

55 

133 

33 

421 

Releases to income statement

(6)

(10)

(48)

(64)

Provisions utilised

(142)

(112)

(3,761)

(35)

(128)

(4,178)

At 30 September 2018

803 

591 

811 

1,042 

3,247 

 

Notes:

(1)

RMBS provision has been redesignated 'DoJ' and the remaining RMBS litigation matters transferred to Litigation and other regulatory as of 1 April 2018 to reflect progress on resolution.

(2)

Refer to Note 2 for further details.

 

 

There are uncertainties as to the eventual cost of redress in relation to certain of the provisions contained in the table above. Assumptions relating to these are inherently uncertain and the ultimate financial impact may be different from the amount provided.  

4. Litigation, investigations and reviews

RBS's 2018 Interim Results, issued on 3 August 2018, included comprehensive disclosures about RBS's litigation, investigations and reviews in Note 11. Set out below are the material developments in these matters since the 2018 Interim Results were published. RBS generally does not disclose information about the establishment or existence of a provision for a particular matter where disclosure of the information can be expected to prejudice seriously RBS's position in the matter.

 

Litigation

London Interbank Offered Rate (LIBOR) and other rates litigation

Certain members of the Group were named as defendants in a class action relating to alleged manipulation of the Singapore Interbank Offered Rate (SGD SIBOR) and Singapore Swap Offer Rate (SOR), which is pending in the United States District Court for the Southern District of New York.

 

Notes

 

4. Litigation, investigations and reviews continued

On 5 October 2018, the court issued its decision on defendants' motion to dismiss the amended complaint in this matter. The court permitted certain antitrust claims to proceed against NatWest Markets Plc and certain other non-RBS defendants, but dismissed all other claims.

 

TeraExchange antitrust litigation

RBS companies, including RBSG, are among the defendants in an antitrust case filed by TeraExchange in which TeraExchange alleges that the defendants conspired to boycott its credit default swap trading platform. On 1 October 2018, the United States District Court for the Southern District of New York dismissed all claims against RBS companies.

 

Total Value Annuity litigation

A class action lawsuit was filed in May 2018 in the United States District Court for Kansas alleging that NatWest Markets Plc conspired with Security Benefit Life Insurance Company and others to defraud purchasers of the Total Value Annuity issued by Security Benefit Life Insurance Company. On 24 October 2018, the plaintiff voluntarily dismissed all claims against NatWest Markets Plc.

 

Thornburg adversary proceeding

Certain RBS companies, including NatWest Markets Plc and NatWest Markets Securities Inc., as well as several other financial institutions, are defendants in an adversary proceeding filed in the US bankruptcy court in Maryland by the trustee for TMST, Inc. (formerly known as Thornburg Mortgage, Inc.). The trustee seeks recovery of transfers made under certain restructuring agreements as, among other things, avoidable fraudulent and preferential conveyances and transfers. On 27 September 2018, the RBS defendants reached an agreement to settle all claims against them for US$23.5 million. The settlement is subject to approval by the bankruptcy court, and the amount is covered by a provision existing as of 30 September 2018.

 

Investigations and reviews

Residential mortgage-backed securities (RMBS) and other securitised products investigations

On 14 August 2018, RBSG (together with its subsidiaries) announced that it had reached a final settlement with the US Department of Justice (DOJ) to resolve its investigation into the issuance and underwriting of RMBS, involving a civil monetary penalty of US$4.9 billion. The settlement amount, which was paid in September, was covered by existing provisions.

 

In October 2017, NatWest Markets Securities Inc. entered into a non-prosecution agreement (NPA) with the United States Attorney for the District of Connecticut (USAO) in connection with alleged misrepresentations to counterparties relating to secondary trading in various form of asset-backed securities. In the NPA, the USAO agreed not to file criminal charges relating to certain conduct and information described in the NPA if NatWest Markets Securities Inc. complies with the NPA during its term. In October 2018, NatWest Markets Securities Inc. agreed to a six-month extension of the NPA while the USAO reviews the circumstances of an unrelated matter reported during the course of the NPA.

 

Payment Protection Insurance (PPI)

An additional provision of £200 million was taken at Q3 2018, reflecting greater than predicted complaints volumes. RBS has made provisions totalling £5.3 billion to date for PPI claims, of which £4.5 billion had been utilised by 30 September 2018.

 

US dollar processing consent order

In December 2013, RBS and NatWest Markets Plc entered into a consent Cease and Desist Order (US Dollar Processing Order) with the Board of Governors of the Federal Reserve System (Federal Reserve) with respect to compliance with OFAC regulations by RBS's global business lines outside the US. RBS made investments in technology, hired and trained personnel, and revised compliance, risk management and other policies and procedures. On 16 October 2018, the Federal Reserve announced the termination of the US Dollar Processing Order. 

5. Post balance sheet events

Alawwal Bank announced in 2017 that it was entering into merger discussions with Saudi British Bank. On 4 October 2018, they announced that terms had been agreed and that they anticipated being able to complete the transaction in H1 2019.

 

On 9 October 2018 NatWest Bank Plc contributed £2 billion to the Main section of the RBS pension fund. This was a consequence of implementing ring fencing requirements envisaged by the Memorandum of Understanding with the Trustee dated 14 April 2018.

 

Other than mentioned, there have been no further significant events between 30 September 2018 and the date of approval of this announcement.

 

Additional information

 

Presentation of information

In this document, 'RBSG plc' or the 'parent company' refers to The Royal Bank of Scotland Group plc, and 'RBS' or the 'Group' refers to RBSG plc and its subsidiaries.

 

Financial information contained in this document does not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006 ('the Act'). The statutory accounts for the year ended 31 December 2017 have been filed with the Registrar of Companies. The report of the auditor on those statutory accounts was unqualified, did not draw attention to any matters by way of emphasis and did not contain a statement under section 498(2) or (3) of the Act.

 

Key operating indicators

As described in Note 1 on page 14, RBS prepares its financial statements in accordance with IFRS as issued by the IASB which constitutes a body of generally accepted accounting principles (GAAP). This document contains a number of adjusted or alternative performance measures, also known as non-GAAP financial measures. These measures exclude certain items which management believe are not representative of the underlying performance of the business and which distort period-on-period comparison. These measures include:

Performance, funding and credit metrics such as 'return on tangible equity', and related RWA equivalents incorporating the effect of capital deductions (RWAes), total assets excluding derivatives (funded assets), net interest margin (NIM) adjusted for items designated at fair value through profit or loss (non-statutory NIM), cost:income ratio and loan:deposit ratio. These are internal metrics used to measure business performance;

Personal & Business Banking (PBB) franchise results, combining the reportable segments of UK Personal & Business Banking (UK PBB) and Ulster Bank RoI, Commercial & Private Banking (CPB) franchise results, combining the reportable segments of Commercial Banking and Private Banking.

The Group also presents a pro forma CET1 ratio which is on an adjusted basis, this has not been prepared in accordance with Regulation S-X and should be read in conjunction with the notes provided as well as the section "Forward-looking statements" below.

 

 

Contacts

Analyst enquiries:

Matt Waymark

Investor Relations

+44 (0) 207 672 1758

Media enquiries:

RBS Press Office

 

+44 (0) 131 523 4205

 

 

Analyst and investor call

Web cast and dial in details

Date:

Friday 26 October 2018

www.rbs.com/results

Time:

9:00 am UK time

International - +44 (0) 20 3009 5755

Conference ID:

3892346

UK Free Call - 0800 279 6637

US Local Dial-In, New York - 1 646 517 5063

 

Available on www.rbs.com/results

Q3 2018 Interim Management Statement and background slides.

A financial supplement containing income statement, balance sheet and segment performance for the nine quarters ended 30 September 2018.

Pillar 3 supplement at 30 September 2018.

 

Forward looking statements

This document contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, including (but not limited to) those related to RBS and its subsidiaries' regulatory capital position and funding requirements, financial position, ongoing litigation and regulatory investigations, profitability and financial performance (including financial performance targets and expectations), structural reform and the implementation of the UK ring-fencing regime, the implementation of RBS's restructuring and transformation programme, impairment losses and credit exposures under certain specified scenarios, increasing competition from new incumbents and disruptive technologies and RBS's exposure to political and economic risks (including with respect to Brexit), operational risk, conduct risk, cyber and IT risk and credit rating risk. In addition, forward-looking statements may include, without limitation, the words 'expect', 'estimate', 'project', 'anticipate', 'commit', 'believe', 'should', 'intend', 'plan', 'could', 'probability', 'risk', 'Value-at-Risk (VaR)', 'target', 'goal', 'objective', 'may', 'endeavour', 'outlook', 'optimistic', 'prospects' and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as RBS's future economic results, business plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations and general economic and political conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK 2017 Annual Report and Accounts (ARA) and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's most recent Annual Report on Form 20-F and Reports on Form 6-K. The forward-looking statements contained in this document speak only as of the date of this document and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRTBRBDGUUDBGIU
Date   Source Headline
22nd Jul 20202:00 pmRNSChange of Name
16th Jul 20207:00 amRNSIntention to Change Name on 22 July 2020
1st Jul 202012:29 pmRNSDirector/PDMR Shareholding
30th Jun 20204:26 pmRNSTotal Voting Rights
29th Jun 20207:00 amRNSNotice of Redemption
25th Jun 20209:19 amRNSRBSG pricing of US$1.5bn Additional Tier 1 Notes
23rd Jun 20207:00 amRNSChanges to the Alternative Remedies Package
11th Jun 20205:31 pmRNSPublication of Supplementary Prospectus
11th Jun 20208:00 amRNSRBS and NatWest Markets announce appointments
8th Jun 20204:15 pmRNSHolding(s) in Company
8th Jun 20203:38 pmRNSTotal Voting Rights and Capital
8th Jun 20203:20 pmRNSDirector/PDMR Shareholding
29th May 20203:09 pmRNSDirector/PDMR Shareholding
29th May 20202:25 pmRNSTotal Voting Rights
29th May 202012:52 pmRNSDividend Declaration
21st May 202010:15 amRNSAdditional Listing
20th May 20207:04 amRNSRBSG pricing of US$1.6bn of Senior Notes
14th May 20201:00 pmRNSDirector/PDMR Shareholding
13th May 20204:01 pmRNSPublication of Final Terms
12th May 202011:16 amRNSQ1 2020 Pillar 3 Supplement
5th May 20204:57 pmRNSPublication of Supplementary Prospectus
1st May 20204:20 pmRNSPublication of Suppl.Prospcts
1st May 20207:00 amRNSQ1 Interim Management Statement
30th Apr 202012:20 pmRNSTotal Voting Rights
29th Apr 20204:33 pmRNSResult of AGM
29th Apr 20203:01 pmRNSAGM Statement
28th Apr 20203:51 pmRNSDirector/PDMR Shareholding
27th Apr 20204:40 pmRNSSecond Price Monitoring Extn
27th Apr 20204:35 pmRNSPrice Monitoring Extension
27th Apr 20203:58 pmRNSDisclosure of rights attached to equity shares
20th Apr 202012:38 pmRNSDividend Declaration
14th Apr 20204:21 pmRNSVirtual Shareholder Event – 29 April 2020
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
6th Apr 20202:14 pmRNSBlock Listing Six Monthly Return
3rd Apr 20204:11 pmRNSAmendment of Final Terms
3rd Apr 20203:24 pmRNSNotice of AGM
2nd Apr 202012:11 pmRNSDirector/PDMR Shareholding
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202011:34 amRNSRoyal Bank of Scotland Group
1st Apr 20207:00 amRNSResponse to Covid-19
26th Mar 20204:42 pmRNSSecond Price Monitoring Extn
26th Mar 20204:37 pmRNSPrice Monitoring Extension
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn
25th Mar 20204:35 pmRNSPrice Monitoring Extension
24th Mar 20204:42 pmRNSSecond Price Monitoring Extn
24th Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.